![Serum not making fresh vaccines amid surplus stock: Poonawalla](https://images.assettype.com/fortuneindia%2F2021-05%2F11fd0f81-d30c-413f-8d5b-eeb71696e5ed%2FGettyImages_1230778554_copy.jpg?rect=0,80,2400,1200&w=300&q=95)
Serum not making fresh vaccines amid surplus stock: Poonawalla
Serum Institute chief executive Adar Poonawalla, during a media event today, said the company has 200 million doses of vaccine stock available currently.
Serum Institute chief executive Adar Poonawalla, during a media event today, said the company has 200 million doses of vaccine stock available currently.
India’s vaccine giant faces the huge social responsibility of supply into the domestic market and a contractual demand for export of vaccines to foreign countries.